<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=213807269037206&amp;ev=PageView&amp;noscript=1">
Compliance In Focus
Posted by John Lehmann on Tue, Feb 11, 2014

Business Threats to the Life Sciences Industry

A recent article in Medical Device and Diagnostic Industry featured CEO’s of globalBusiness Threats to the Life Sciences Industry pharmaceutical and life sciences companies commenting on business threats in 2014.  The article points out that these CEO’s are wary of many threats because of multiple changes in the healthcare industry  that are impacting business models.

In a 2014 global survey of CEOs conducted by PricewaterhouseCoopers, pharmaceutical and life sciences CEOs ranked the most concerning threats. Here is a listing of their most serious threats:

  • Inability to protect intellectual property
  • Bribery and corruption
  • Cyber threats and a lack of data security
  • New entrants into market place
  • Lack of trust in business
  • Availability of skills
  • Disruption of supply chain
  • Shift in consumer spending and behaviors

The article provides  further statistical breakdown for each item cited on the list, but one the encouraging takeaways is that 90% of the CEOs responded that they are somewhat or very confident of growth over the next three years.  This is an encouraging sign!

Do you have any items you think she be added to the list of business threats in 2014 that should be included in the list? Please share below.

Photo Credit: ryanovineyards

Drugs & Devices Trial Guideline

Topics: Life Sciences Industry, Business Threats, Medical Device and Diagnostic Industry


Posts by Topic: